tm
Seeing Is Believing
tm
Seeing Is Believing
Antares Pharma's activity chart (see below) currently has 32 price targets and 23 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35.19% with an average time for these price targets to be met of 241.33 days.
Most recent stock forecast was given by ELLIOT WILBUR from on 14-Apr-2022. First documented stock forecast 08-Oct-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Apr-2022
$6
$0.41 (7.33%)
$6
4 years 6 months 18 days ago
(14-Apr-2022)
0/3 (0%)
$0.44 (7.91%)
Buy Since 23-Oct-2017
$5.6
$0.01 (0.18%)
$6
4 years 6 months 18 days ago
(14-Apr-2022)
1/3 (33.33%)
$0.04 (0.72%)
294
Buy Since 08-Oct-2013
$5
4 years 6 months 18 days ago
(14-Apr-2022)
11/12 (91.67%)
$1.22 (32.28%)
380
Hold Since 13-Apr-2022
$7
4 years 6 months 20 days ago
(13-Apr-2022)
0/1 (0%)
$2.85 (68.67%)
Buy Since 09-Mar-2016
$8
$2.41 (43.11%)
$7
7 years 11 months 26 days ago
(06-Nov-2018)
1/3 (33.33%)
$4.39 (121.61%)
412
What is ATRS (Antares Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on ATRS (Antares Pharma)?
Which analyst has the most public recommendations on ATRS (Antares Pharma)?
Which analyst is the currently most bullish on ATRS (Antares Pharma)?
Which analyst is the currently most reserved on ATRS (Antares Pharma)?
